Chunxiao Wang
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 12
- MicroRNA in disease regulation 7
- Cancer, Lipids, and Metabolism 7
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis 11
-
- Circular RNAs in diseases 8
- RNA modifications and cancer 4
-
- Pancreatic and Hepatic Oncology Research 5
-
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Dazhi FuRui YuLei YuMingzhen WangKylie M. WagstaffDavid A. JansSatoru WatanabeJingdi Chen
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Chunxiao Wang
79 papers receiving 969 citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Cancer Research 273
- Hepatology 87
- Pulmonary and Respiratory Medicine 219
- Molecular Biology 456
- Biomaterials 70
Countries citing papers authored by Chunxiao Wang
This map shows the geographic impact of Chunxiao Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chunxiao Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chunxiao Wang more than expected).
Fields of papers citing papers by Chunxiao Wang
This network shows the impact of papers produced by Chunxiao Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chunxiao Wang. The network helps show where Chunxiao Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chunxiao Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 11 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 33 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 7 | |
| 13 | 2022 | 4 | |
| 14 | 2022 | 5 | |
| 15 | 2021 | 42 | |
| 16 | 2019 | 1 | |
| 17 | Wnt5a through noncanonical Wnt/JNK signaling promotes the differentiation of human embryonic stem cells to lentoid bodies | 2018 | 1 |
| 18 | Golph3 expression and apoptosis in colorectal cancer cells | 2013 | 2 |
| 19 | 2013 | 2 | |
| 20 | 2012 | 5 |
About Chunxiao Wang
Chunxiao Wang is a scholar working on Cancer Research, Hepatology and Biomaterials, having authored 87 papers that have together received 985 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Circular RNAs in diseases (8 papers), MicroRNA in disease regulation (7 papers), Cancer, Lipids, and Metabolism (7 papers), Pancreatic and Hepatic Oncology Research (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (273 citations), Hepatology (87 citations) and Pulmonary and Respiratory Medicine (219 citations). Chunxiao Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Dazhi Fu, Rui Yu, Lei Yu, Mingzhen Wang, Kylie M. Wagstaff, David A. Jans, Satoru Watanabe, Jingdi Chen, Patrick M. Sexton and Belinda Maher. Their work appears in journals such as Advanced Materials, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.